Capacity Development through the US President's Malaria Initiative-Supported Antimalarial Resistance Monitoring in Africa Network.
Capacity Development through the US President's Malaria Initiative-Supported Antimalarial Resistance Monitoring in Africa Network.
复制标题
DOI：
10.3201/eid2313.170366
复制
发表时间：
2017-12
影响因子：
11.8
通讯作者：
Udhayakumar V
中科院分区：
文献类型：
--
作者：
Halsey ES;Venkatesan M;Plucinski MM;Talundzic E;Lucchi NW;Zhou Z;Mandara CI;Moonga H;Hamainza B;Beavogui AH;Kariuki S;Samuels AM;Steinhardt LC;Mathanga DP;Gutman J;Denon YE;Uwimana A;Assefa A;Hwang J;Shi YP;Dimbu PR;Koita O;Ishengoma DS;Ndiaye D;Udhayakumar V
抗疟疾药物耐药性是对疟疾控制的一个不断演变的全球卫生安全威胁。通过治疗效果研究和相关的遗传分析及早发现恶性疟原虫耐药性，可能有助于及时实施干预战略。美国总统疟疾倡议支持的非洲抗疟疾耐药性监测网络帮助伙伴国家的许多实验室获得了独立监测抗疟疾耐药性分子标志物的知识和能力。
Antimalarial drug resistance is an evolving global health security threat to malaria control. Early detection of Plasmodium falciparum resistance through therapeutic efficacy studies and associated genetic analyses may facilitate timely implementation of intervention strategies. The US President’s Malaria Initiative–supported Antimalarial Resistance Monitoring in Africa Network has assisted numerous laboratories in partner countries in acquiring the knowledge and capability to independently monitor for molecular markers of antimalarial drug resistance.